From: Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study
Quartile | Range | Educational, N (%) | Non-educational, N (%) | P-value |
---|---|---|---|---|
Transportation |  > 75 | 21 (100.0) | 12 (100.0) | – |
Handling and storage | 50–75 | 3 (14.3) | 0 | 0.284 |
 > 75 | 18 (85.7) | 12 (100.0) | ||
Vaccine preparation | < 50 | 0 | 1 (8.3) | 0.599 |
50–75 | 4 (19.0) | 2 (16.7) | ||
> 75 | 17 (81.0) | 9 (75.0) | ||
Pfizer preparation | 50–75 | 2 (15.4) | 2 (28.6) | 0.587 |
> 75 | 11 (84.6) | 5 (71.4) | ||
AstraZeneca preparation | > 75 | 8 (100.0) | 5 (100.0) | – |
Pre-vaccination | < 50 | 1 (4.8) | 3 (25.0) | 0.186 |
50–75 | 1 (4.8) | 0 | ||
> 75 | 19 (90.5) | 9 (75.0) | ||
Administration | > 75 | 21 (100.0) | 12 (100.0) | – |
Post-vaccination | 50–75 | 3 (14.3) | 3 (25.0) | 0.643 |
> 75 | 18 (85.7) | 9 (75.0) | ||
Total | > 75 | 21 (100.0) | 12 (100.0) | – |